STK17A antibody - C-terminal region
Rabbit Polyclonal Antibody
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application
| WB |
---|---|
Primary Accession | Q9UEE5 |
Other Accession | NM_004760, NP_004751 |
Reactivity | Horse, Bovine, Guinea Pig, Dog |
Predicted | Chicken, Horse, Bovine, Guinea Pig, Dog |
Host | Rabbit |
Clonality | Polyclonal |
Calculated MW | 46kDa |
Gene ID | 9263 |
---|---|
Alias Symbol | DRAK1 |
Other Names | Serine/threonine-protein kinase 17A, 2.7.11.1, DAP kinase-related apoptosis-inducing protein kinase 1, STK17A, DRAK1 |
Format | Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. |
Reconstitution & Storage | Add 50 ul of distilled water. Final anti-STK17A antibody concentration is 1 mg/ml in PBS buffer with 2% sucrose. For longer periods of storage, store at 20°C. Avoid repeat freeze-thaw cycles. |
Precautions | STK17A antibody - C-terminal region is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | STK17A |
---|---|
Synonyms | DRAK1 |
Function | Acts as a positive regulator of apoptosis. Also acts as a regulator of cellular reactive oxygen species. |
Cellular Location | Nucleus. |
Tissue Location | Highly expressed in placenta. Lower levels in heart, lung, skeletal muscle, kidney and pancreas |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Acts as a positive regulator of apoptosis. Also acts as a regulator of cellular reactive oxygen species.
References
Sanjo H.,et al.J. Biol. Chem. 273:29066-29071(1998).
Scherer S.W.,et al.Science 300:767-772(2003).
Hillier L.W.,et al.Nature 424:157-164(2003).
Mural R.J.,et al.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
Kerley-Hamilton J.S.,et al.Oncogene 24:6090-6100(2005).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.